UPDATE
: Friday, February 22, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Regulator OKs Bukwang’s anticancer treatment
Bukwang Pharmaceutical said Thursday that the Ministry of Food and Drug Saf...
by Lee Han-soo
|
2019-02-22 15:29
라인
Will first-ever treatment for nonalcoholic fatty liver arrive?
Pharmaceutical firms around the world are striving to become the world’s fi...
by Kim Yun-mi
|
2019-02-22 15:29
라인
Hugel hits record-high quarterly sales
Hugel said Friday it registered highest quarterly turnover in the final thr...
by Lee Han-soo
|
2019-02-22 13:30
라인
Huons posts record-high sales in 2018
Huons said Wednesday that it registered 328.6 billion won ($291.9 million) ...
by Lee Han-soo
|
2019-02-21 17:17
라인
Mediforum verifies safety, efficacy of dementia treatment candidate
Mediforum said Thursday it has verified the safety and efficacy of PM012, a...
by Lee Han-soo
|
2019-02-21 15:13
라인
DPP-4 inhibitors raise bullous pemphigoid risk in diabetic patients: study
Inhibitors of dipeptidyl peptidase 4 (DPP-4), used to treat diabetes, can i...
by Kim Yun-mi
|
2019-02-21 15:13
라인
Xtandi adds indication for non-metastatic castration-resistant prostate cancer
Astellas Pharma Korea said it obtained regulatory approval for Xtandi (ingr...
by Kim Yun-mi
|
2019-02-21 15:10
라인
SCM, Allele to develop diabetes treatment
SCM Life Science said Thursday it has signed a joint research agreement wit...
by Lee Han-soo
|
2019-02-21 14:57
라인
Pfizer’s patent barrier foils Korea’s 1st pneumococcal conjugate vaccine
SK Bioscience’s Skypheumo, a pneumococcal conjugate vaccine (PCV) approval,...
by Lee Han-soo
|
2019-02-20 16:18
라인
FDA rejects Medytox’s ‘citizen petition’ against Daewoong
Daewoong Pharmaceutical said Wednesday that the FDA rejected Medytox’s “cit...
by Lee Han-soo
|
2019-02-20 14:37
라인
Court suspends FSC’s disciplinary action against Samsung BioLogics
The Seoul Administrative Court Tuesday suspended the Financial Services Com...
by Lee Han-soo
|
2019-02-20 12:12
라인
Chong Kun Dang unveils trial results for erectile dysfunction treatment
Chong Kun Dang said Monday that it has presented the clinical trial results...
by Lee Han-soo
|
2019-02-19 17:36
라인
Yuhan’s sales reached ₩1.5 trillion in 2018
Yuhan Corp. said Monday that it recorded 1.5 trillion won ($1.3 billion) in...
by Lee Han-soo
|
2019-02-19 16:06
라인
Pharma Research Bio wins nod to export botulinum toxin
Pharma Research Bio said it obtained approval from the Ministry of Food and...
by Lee Hye-seon
|
2019-02-19 15:46
라인
[News Focus] Will MSD’s new antidiabetic SGLT-2 inhibitor prove effective?
Whether MSD’s ertugliflozin, a new antidiabetic SGLT-2 (sodium-glucose cotr...
by Kim Yun-mi
|
2019-02-19 14:31
라인
Does anticoagulant Eliquis work on children?
The Ministry of Food and Drug Safety has allowed BMS Korea to conduct a pha...
by Lee Hye-seon
|
2019-02-19 10:53
라인
Technoclone to supply Handok diagnostic reagent for ADAMTS-13 activity test
Handok said Monday that it has signed an agreement with Technoclone, an Aus...
by Lee Han-soo
|
2019-02-18 16:38
라인
‘Hair loss drug Propesia works well for Koreans in long term’
MSD Korea’s Propesia (ingredient: finasteride), which has been used as male...
by Kim Yun-mi
|
2019-02-18 16:38
라인
Hanmi’s RaboneD dominates osteoporosis therapy market
Hanmi Pharmaceutical’s RaboneD, an osteoporosis treatment in the selective ...
by Kim Yun-mi
|
2019-02-18 14:23
라인
Humedix posts record-high sales in Q4 sales
Humedix said Friday that its earnings turned around and has posted record-h...
by Lee Han-soo
|
2019-02-18 14:22
-
1
2
3
4
5
6
7
8
9
10
다음
-
Insurance benefit for breast cancer treatment ‘Faslodex’ put on hold
Celltrion Healthcare posts ₩713.5 billion in 2018 sales
Alteogen applies for P1 trial for Eylea biosimilar
[News Focus] Why did court acquit Ewha hospital staffs in newborns’ death case?
Insurance benefit for breast cancer treatment ‘Faslodex’ put on hold
Celltrion Healthcare posts ₩713.5 billion in 2018 sales
Alteogen applies for P1 trial for Eylea biosimilar
[News Focus] Why did court acquit Ewha hospital staffs in newborns’ death case?
여백
Most viewed
1
‘Hair loss drug Propesia works well for Koreans in long term’
2
Pfizer’s patent barrier foils Korea’s 1st pneumococcal conjugate vaccine
3
Government to spend ₩3 trillion on innovative drugs, dementia, medical scientists
4
Ministry OKs Peptron’s P2 clinical trial of Parkinson’s disease treatment
5
State research organ finds new genes expediting gastritis, gastric cancer
6
Hanmi’s RaboneD dominates osteoporosis therapy market
7
Technoclone to supply Handok diagnostic reagent for ADAMTS-13 activity test
8
Severance Hospital transfers colorectal cancer treatment candidate to Israeli firm
9
[News Focus] Will MSD’s new antidiabetic SGLT-2 inhibitor prove effective?
10
Pharma Research Bio wins nod to export botulinum toxin
여백
Opinion
[Reporter’s Notebook] TV dramas misportray mental hospitals
[Column] Patient stabbed doctor to death -- things can’t just go on like this
[Column]Korea’s healthcare industry; do flowers blossom in desert, too?
여백
Back to Top